Supplement Claims On Duration Of Cold, Menopausal Support Fail In UK Reviews
This article was originally published in The Tan Sheet
Executive Summary
The Advertising Standards Authority says Swedish firm Enymatica misses the mark for supporting ColdZyme supplement claims and UK firm PharmaCare’s ads for the Promensil menopause symptoms supplement run afoul of the rule it cites as support.
You may also be interested in...
Reformulated Zicam Nasal Swabs Return Matrixx To Top Sales Category
Matrixx Initiatives re-launches Zicam Cold Remedy Nasal Swabs with “plant-based ingredients” replacing the original product’s zinc gluconate. Consumer trust in the Zicam brand prompted the reformulation and re-launch, says CEO M’lou Walker.
Matrixx Keeps “Pre-Cold” With NAD Ad Victory
Matrixx’s use of “The Pre-Cold Medicine” in the context of the challenged ads does not “reasonably convey a message that Zicam is effective in preventing colds or should be used by consumers for that purpose,” the National Advertising Review Board says.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.